All In MedTech

FDA Clearance Tracker · P160017-S125

MiniMed 780G System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 11, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 11, 2025

Approved

Time to decision

225 days

Received Apr 30, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P160017-S125
Device name
MiniMed 780G System
Applicant location
Northridge, CA
Received
Apr 30, 2025
Decided
Dec 11, 2025
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P160017

Device type

Device class
Class III

Every decision under product code OZP

FDA's approval statement

As written in FDA's record.

Approval of expanding the compatible insulins for use with the MiniMed 780G system to include Fiasp and Lyumjev.

Source documents

Other decisions for Medtronic Minimed, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.